✦ LIBER ✦

IFN-stimulated Gene Expression Is a Useful Potential Molecular Marker of Response to Antiviral Treatment with Peg-IFNα 2b and Ribavirin in Patients with Hepatitis C Virus Genotype 1

✍ Scribed by María Sara Sixtos-Alonso; Fausto Sánchez-Muñoz; Juan Francisco Sánchez-Ávila; Rosalba Avalos Martínez; Aaron Domínguez López; Florencia Vargas Vorácková; Misael Uribe

Book ID: 113467471
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 114 KB
Volume: 42
Category: Article
ISSN: 0188-4409
DOI: 10.1016/j.arcmed.2011.01.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pegylated interferon alpha-2b (Peg-IFN α

Pegylated interferon alpha-2b (Peg-IFN α-2b) affects early virologic response dose-dependently in patients with chronic hepatitis C genotype 1 during treatment with Peg-IFN α-2b plus ribavirin

✍ T. Oze; N. Hiramatsu; T. Yakushijin; M. Kurokawa; T. Igura; K. Mochizuki; K. Ima 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB

[779] ANTIVIRAL RESPONSE AT WEEK 12 FOLL

[779] ANTIVIRAL RESPONSE AT WEEK 12 FOLLOWING COMPLETION OF TREATMENT WITH ALBINTERFERON a-2b PLUS RIBAVIRIN IN GENOTYPE 1, IFN-NAIVE, CHRONIC HEPATITIS C PATIENTS

✍ S. Zeuzem; Y. Benhamou; V. Bain; D. Shouval; S. Pianko; R. Flisiak; M. Grigoresc 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 133 KB

OC-10 IL28B genotype, differential expre

OC-10 IL28B genotype, differential expression of intrahepatic interferon-stimulated genes and response to PEG-IFN and ribavirin therapy in an Italian prospective cohort of genotype 1 hepatitis C patients in “real life”

✍ B. Testoni; C. Scisciani; S. Grimaudo; S. Maimone; T. Pollicino; V. Di Marco; G. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Early viral clearance is important for a

Early viral clearance is important for achieving sustained viral response even in high dose induction treatment with IFNα-2B + ribavirin for chronic hepatitis C patients with genotype 1B and high viral load (more than 500 kcopies): Norio Hayashi, Osaka University, Osaka Japan; Kyuichi Tanikawa, International Institute for Liver Research, Kurume Japan; Hiroshi Suzuki, Yananashi University School of Medicine, Yokohama Japan; Shiro Iino, St-Marianna University School of Medicine, Kawasaki Japan; Koichi Kanai, Toshiba Hospital, Tokyo Japan; Japan Ribavirin Study Group, Japan, Osaka Japan

📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 216 KB